[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

NO20001198D0 - Pyrrolopyrrole substituents as inhibitors of neutrophil elastase - Google Patents

Pyrrolopyrrole substituents as inhibitors of neutrophil elastase

Info

Publication number
NO20001198D0
NO20001198D0 NO20001198A NO20001198A NO20001198D0 NO 20001198 D0 NO20001198 D0 NO 20001198D0 NO 20001198 A NO20001198 A NO 20001198A NO 20001198 A NO20001198 A NO 20001198A NO 20001198 D0 NO20001198 D0 NO 20001198D0
Authority
NO
Norway
Prior art keywords
pyrrolopyrrole
substituents
inhibitors
neutrophil elastase
elastase
Prior art date
Application number
NO20001198A
Other languages
Norwegian (no)
Other versions
NO20001198L (en
Inventor
Geoffrey Duke Edward Clarke
Michael Dennis Dowle
Harry Finch
Lee Andrew Harrison
Graham George Adam Inglis
Martin Redpath Johnson
Simon John Fawcett Macdonald
Pritom Shah
Robin Andrew Smith
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9719183.7A external-priority patent/GB9719183D0/en
Priority claimed from GBGB9719189.4A external-priority patent/GB9719189D0/en
Priority claimed from GBGB9719290.0A external-priority patent/GB9719290D0/en
Priority claimed from GBGB9803611.4A external-priority patent/GB9803611D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of NO20001198D0 publication Critical patent/NO20001198D0/en
Publication of NO20001198L publication Critical patent/NO20001198L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
NO20001198A 1997-09-09 2000-03-08 Pyrrolopyrrole subunits as inhibitors of neutrophil elastase NO20001198L (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GBGB9719183.7A GB9719183D0 (en) 1997-09-09 1997-09-09 Compounds
GBGB9719189.4A GB9719189D0 (en) 1997-09-09 1997-09-09 New therapeutic method
GBGB9719290.0A GB9719290D0 (en) 1997-09-10 1997-09-10 Compounds
GBGB9803611.4A GB9803611D0 (en) 1998-02-21 1998-02-21 Compounds
PCT/EP1998/005609 WO1999012933A2 (en) 1997-09-09 1998-09-07 Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase

Publications (2)

Publication Number Publication Date
NO20001198D0 true NO20001198D0 (en) 2000-03-08
NO20001198L NO20001198L (en) 2000-05-08

Family

ID=27451698

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20001198A NO20001198L (en) 1997-09-09 2000-03-08 Pyrrolopyrrole subunits as inhibitors of neutrophil elastase

Country Status (24)

Country Link
EP (1) EP1003748A2 (en)
JP (1) JP2001515904A (en)
KR (1) KR20010023766A (en)
CN (1) CN1278820A (en)
AP (1) AP2000001761A0 (en)
AR (1) AR017072A1 (en)
AU (1) AU9741298A (en)
BR (1) BR9812062A (en)
CA (1) CA2303176A1 (en)
CO (1) CO4970719A1 (en)
EA (1) EA200000204A1 (en)
EE (1) EE200000138A (en)
HU (1) HUP0004644A3 (en)
ID (1) ID24452A (en)
IL (1) IL134791A0 (en)
IS (1) IS5391A (en)
MA (1) MA26543A1 (en)
NO (1) NO20001198L (en)
NZ (1) NZ503130A (en)
PE (1) PE107899A1 (en)
PL (1) PL339176A1 (en)
SK (1) SK3192000A3 (en)
TR (1) TR200000907T2 (en)
WO (1) WO1999012933A2 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9905418D0 (en) * 1999-03-09 1999-05-05 Glaxo Group Ltd Process
DE602005025222D1 (en) 2004-03-31 2011-01-20 Janssen Pharmaceutica Nv Heterocyclic nonimidazole compounds as histamine H3 receptor modulators
DE102004024772A1 (en) * 2004-05-17 2005-12-22 Grünenthal GmbH Substituted 5-aminomethyl-1H-pyrrole-2-carboxamides
JP4853759B2 (en) * 2004-05-27 2012-01-11 日本農薬株式会社 Substituted pyrazinecarboxylic acid anilide derivatives or salts thereof, intermediates thereof, agricultural and horticultural agents, and methods of use thereof
TWI355380B (en) 2004-05-27 2012-01-01 Nihon Nohyaku Co Ltd Substituted pyrazinecarboxanilide derivatives or s
GB2418427A (en) 2004-09-02 2006-03-29 Univ Cambridge Tech Ligands for G-protein coupled receptors
KR20070084455A (en) 2004-11-23 2007-08-24 워너-램버트 캄파니 엘엘씨 7-(2h-pyrazol-3-yl)-3,5-dihydroxy-heptanoic acid derivatives as hmg co-a reductase inhibitors for the treatment of lipidemia
US8198288B2 (en) 2006-05-04 2012-06-12 Pulmagen Therapeutics (Inflammation) Limited Tetrahydropyrrolopyrimidinediones and their use in therapy
EA018061B1 (en) 2006-05-04 2013-05-30 Пульмаджен Терапьютикс (Инфлэмэйшн) Лимитед Tetrahydropyrrolopyrimidinediones and their use as human neutrophil elastase inhibitors
GB2452696B (en) 2007-08-02 2009-09-23 Cambridge Entpr Ltd 3-(2',2'-dimethylpropanoylamino)-tetrahydropyridin-2-one and its use in pharmaceutical compositions
US7662967B2 (en) 2007-08-02 2010-02-16 Cambridge Enterprise Limited Anti-inflammatory compounds and compositions
WO2009060206A1 (en) * 2007-11-07 2009-05-14 Argenta Discovery Limited 3,4,6,7-tetrahydro-1h-pyrrolo[3,4-d]pyrimidine-2,5-diones and their therapeutic use
US20110212181A1 (en) * 2010-02-26 2011-09-01 The University Of Hong Kong Compositions and methods for treating chronic respiratory inflammation
US20220354833A1 (en) 2019-09-17 2022-11-10 Mereo Biopharma 4 Limited Alvelestat for use in the treatment of graft rejection, bronchiolitis obliterans syndrome and graft versus host disease
PL4106757T3 (en) 2020-04-16 2024-01-22 Mereo Biopharma 4 Limited Methods involving neutrophil elastase inhibitor alvelestat for treating respiratory disease mediated by alpha-1 antitrypsin deficiency
WO2023067103A1 (en) 2021-10-20 2023-04-27 Mereo Biopharma 4 Limited Neutrophil elastase inhibitors for use in the treatment of fibrosis

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9211783D0 (en) * 1992-06-04 1992-07-15 Ici Plc Amide derivatives
GB9402680D0 (en) * 1994-02-11 1994-04-06 Zeneca Ltd Pyrrolidine derivatives
EE9800335A (en) * 1996-03-28 1999-04-15 Glaxo Group Limited Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase

Also Published As

Publication number Publication date
IL134791A0 (en) 2001-04-30
CA2303176A1 (en) 1999-03-18
AR017072A1 (en) 2001-08-22
WO1999012933A2 (en) 1999-03-18
EA200000204A1 (en) 2000-10-30
AU9741298A (en) 1999-03-29
SK3192000A3 (en) 2001-03-12
EP1003748A2 (en) 2000-05-31
WO1999012933A3 (en) 1999-05-27
CN1278820A (en) 2001-01-03
AP2000001761A0 (en) 2000-03-31
PL339176A1 (en) 2000-12-04
HUP0004644A3 (en) 2002-01-28
MA26543A1 (en) 2004-12-20
HUP0004644A2 (en) 2001-09-28
TR200000907T2 (en) 2000-11-21
NO20001198L (en) 2000-05-08
CO4970719A1 (en) 2000-11-07
EE200000138A (en) 2001-02-15
PE107899A1 (en) 1999-11-17
KR20010023766A (en) 2001-03-26
NZ503130A (en) 2001-08-31
BR9812062A (en) 2000-09-26
JP2001515904A (en) 2001-09-25
ID24452A (en) 2000-07-20
IS5391A (en) 2000-02-29

Similar Documents

Publication Publication Date Title
FI944804A (en) Pyrimidinylacetamide as elastase inhibitors
NO992821D0 (en) Ketobenzamides as Calpain Inhibitors
NO20012984D0 (en) Succinoylamino benzodiazepines as inhibitors of AB protein production
ATE245142T1 (en) NO-SYNTHASE INHIBITORS
IS5574A (en) Substituting the Xa component of the oxo-heterocyclyl inhibitor
IT1276979B1 (en) FLUOROELASTOMERIC COMPOSITIONS
DK0907056T3 (en) Refrigeration plant
DK1033541T3 (en) Refrigeration plant
FI20001086A (en) 2-Phenyl-substituted imidazotriations as phosphodiesterase inhibitors
DK0891362T3 (en) Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase
NO20001198D0 (en) Pyrrolopyrrole substituents as inhibitors of neutrophil elastase
ATE460424T1 (en) FACTOR VIIA INHIBITORS
DK1027332T3 (en) New lactametalloprotease inhibitors
DE69908387D1 (en) Plant activator
ID24361A (en) COMPRESSOR TOOLS
DE59505338D1 (en) COMPRESSOR
NO20010331D0 (en) Phthalazine derivatives as phosphodiesterase 4 inhibitors
FI973211A0 (en) Proline derivatives useful as human leukocyte elastase inhibitors
NO991316D0 (en) 3-mercaptoacetylamino-1,5-substituted-2-oxo-azepane derivatives useful as inhibitors of matrix metalloproteinase
DE69733263D1 (en) MARKED ELASTASE INHIBITORS
EE200000137A (en) Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase
ATE221065T1 (en) AMIDENE DERIVATIVES AS NO-SYNTHASE INHIBITORS
ID23519A (en) COMPRESSOR TYPE OF STOCK PLANTS
IT1292361B1 (en) VOLCANIZABLE FLUOROELASTOMERIC COMPOSITIONS
IT1293327B1 (en) REFRIGERANT COMPOSITIONS

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application